Background/Aims: Retinal neurodegeneration is an early event in the pathological process of diabetic retinopathy (DR). Retinal ganglion cell (RGC) injury is an important pathological feature during neurodegenerative process. Protecting RGCs from high glucose-induced injury is a promising strategy for delaying or hindering diabetes mellitus-related retinal neuropathy. This study aims to investigate the role of Nmnat1, an enzyme which catalyzes a key step in the biosynthesis of nicotinamide adenine dinucleotide (NAD), in high glucose-induced RGC injury. Methods: Nmnat1 expression pattern in the retina and RGC-5 cell. MTT assay, Hoechst staining, trypan blue staining, and calcein-AM/ propidium iodide (PI) staining was conducted to determine the effect of Nmnat1 knockdown on RGC-5 cell function. Microarray and bioinformatics analysis was conducted to identify potential signaling pathways affected by Nmnat1 knockdown. Pharmacological intervention, molecular intervention, and in vitro experiments were conducted to reveal molecular mechanism of Nmnat1-mediated protective effect on RGC-5 cell function. Results: Nmnat1 is constitutively expressed in retina and RGC-5 cells. Nmnat1 knockdown aggravates RGC injury, and accelerates the development of RGC-5 cell apoptosis upon high glucose stress. MAPK signaling is the primary signaling pathway affected by Nmnat1 knockdown. Under high glucose stress, Nmnat1 knockdown leads to p38-MAPK signaling inactivation. p38-MAPK pathway inhibitor strongly blocks Nmnat1-mediated protective effect on RGC-5 cell function. Conclusion: Nmnat1 protects RGC against high glucose-induced injury via p38-MAPK signaling pathway. Nmnat1 may serve as a neuroprotective target for diabetes mellitus-related retinal neuropathy.
Introduction
Diabetic retinopathy (DR) is the leading cause of vision impairment and blindness in both developing and developed countries [1] . Microvascular dysfunction is an important hallmark of DR. Thus, DR is often considered as a microcirculatory disease of retina [2] . Recently, increasing studies have revealed that retinal neurodegeneration is also involved in the pathogenesis of DR, which contributes to the development of microvascular abnormalities [3] [4] [5] . Understanding the mechanism of retinal neurodegeneration contributes to the development of new prevention and treatment strategies for DR.
Neural apoptosis and reactive gliosis are the important features of retinal neurodegeneration during DR [6] . Retinal ganglions cells (RGCs) located in the inner retina has been reported in rats with streptozotocin (STZ)-induced diabetes, and diabetic patients without or with only minimal DR [8, 9] . Thus, protecting RGCs from high glucose-induced injury could delay or hinder DR-related retinal neurodegeneration.
Nicotinamide mononucleotide adenylyltransferase (Nmnat) constitutes an NAD + salvage/recycling pathway using NAM as the precursor in mammalian cells. To date, three S ) mouse model. S with Nmnat1 activity leads to axonal protective phenotype in these mice [10, 11] . Both mammalian Nmnat1 and Drosophila S protein [12] [13] [14] . In some experimental systems, Nmnat enzymatic activity is critical for neuronal protection phenotype [12, 15] . However, the role of Nmnat1 in DRrelated retinal neurodegeneration is still unclear.
In this study, we show that Nmnat1 is constitutively expressed in retina and RGC-5 cell. Nmnat1 knockdown could aggravate RGC damage, and accelerate the development of RGC apoptosis. Under high glucose stress, Nmnat1-mediated protective effect on RGC function is mainly mediated through p38-MAPK signaling pathway. Nmnat1 may become a promising therapeutic target for the treatment of DR-related retinal neurodegeneration.
Materials and Methods

Cell culture and transfection
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manufacturer's instruction.
Pharmacological intervention
RGC-5 cells were transfected with Nmnat1 siRNA or Nmnat1 plasmid to change Nmnat1 expression Sigma Chemical.
Western blot analysis RGC-5 cells were incubated with high glucose for 48 h (30 mM) with or without Nmnat1 siRNA transfection, and then washed with ice-cold PBS. These cells were homogenized in lysis buffer, and centrifuged at 12,000 g for 15 min. Protein concentration was detected using BCA assay. Protein (30 g)
Results
Detection of Nmnat1 expression pattern in retina and RGC-5 cell
Nmnat1 is a protein involved in mammalian NAD + salvage/recycling signaling. Its expression is regulated by nutrient and stress in a number of human cell lines and primary many tissues [18] [19] [20] [21] , it is still unknown whether it is expressed in retina and RGC-5 cell.
expressed in the inner plexiform layer, outer plexiform layer, and ganglion cell layer of mouse cytoplasm of RGC-5 cell (Fig. 1C) .
Nmnat1 knockdown affects RGC-5 cell function in vitro
To reveal the functional relevance of Nmnat1 in response to high glucose stress, we determined the effect of Nmnat1 knockdown on RGC function in vitro reduced RGC-5 cell viability ( Fig. 2C ) as detected by trypan blue staining and MTT assay. Nmnat1 knockdown could further reduce the viability of RGC-5 cells ( Fig. 2B and 2C ). To determine whether Nmnat1 regulates the development of high glucose-induced apoptosis, RGC-5 cells were treated with Nmnat1 siRNA, scrambled siRNA, or left untreated, followed by high glucose treatment. Compared with high glucose-treated group, the combination of Nmnat1 knockdown and high glucose treatment resulted in higher apoptotic 
A representative immunoblot was shown along with the densitometric q u a n t i t a t ive Nmnat1 knockdown leads to inaction of p38-MAPK signaling inaction. To further examine whether p38 is involved in Nmnat1-mediated protective effect on RGC-5 cell function, Nmnat1 was overexpressed in RGC-5 cells. These cells were pretreated with SB203580, U0126, or SP600125, and then exposed to high glucose for 48 h. MTT assays showed that SB203580, a p38-MAPK signaling inhibitor, strongly blocked Nmnat1-mediated protective treatment did not affect Nmnat1-mediated protective effect on RGC-5 cell function (Fig.  4C) . Hoechst 33342 staining showed that Nmnat1 overexpression decreased high glucose- Nmnat1 encodes an enzyme which catalyzes a key step in the biosynthesis of nicotinamide adenine dinucleotide (NAD), which is highly conserved from archaebacteria to human [22] . Studies in Drosophila and mice have revealed a neuroprotective role of Nmnat1 in neurodegenerative conditions including tauopathies, Charcot-Marie-Tooth (CMT) neurodegeneration [23] [24] [25] [26] . In this study, we reveal a role of Nmnat1 in diabetes mellitusrelated retinal neurodegeneration. Nmnat1 could protect RGCs against high glucose-induced injury in vitro.
Hyperglycemia could lead to the apoptosis of both retinal neurons and vascular cells [28, 29] . RGCs are located in the inner retina, and are easily injured in response to high glucose stress. Nmnat1 knockdown could aggravate RGC injury, and accelerate the development of RGC apoptosis, suggesting a protective role of Nmnat1. A recent study has revealed that cytoplasmic overexpression of Nmnat1 could protect mouse retinal ganglion cell axons and soma against from glaucomatous and ischemic-induced injury [30] , also suggesting a protective role of Nmnat1 under stress condition. Taken together, Nmnat1 is emerged as a security guard of RGCs in response to stress.
To understand the mechanism of Nmnat1-mediated protective effect on RGC function, we conducted genome-wide analysis of gene expression through microarray, which can enriched GOs targeted by differentially expressed mRNAs were regulation of transcription knockdown may affect gene transcription, which in turn affects the expression of genes associated with RGC function. Signaling pathway analysis provides the knowledge about expressed mRNAs are most enriched in MAPK signaling pathway. MAPK family is a common participant in mediating growth factor receptor as well as adhesive and tensional signals from the cell surface to the nucleus. They are activated in response to physiological angiogenic stimuli, such as elevated shear stress and mechanical stretch [31, 32] . The activation of MAPK signaling in RGCs may be responsible for diverse downstream actions such as cell proliferation, cell apoptosis, and electrical signal transduction.
Microarray and bioinformatics analysis suggests that Nmnat1 knockdown affects the activity of MAPK signaling. Thus, we investigated the involvement of MAPK signaling in Nmnat1-mediated protective effect on RGC function. MAPKs are a family of serine/threonine signaling. SB203580, a p38 MAPK pathway inhibitor, strongly blocks the effect of Nmnat1-mediated protective effect on RGC function, suggesting that p38-MAPK signaling is mainly involved in Nmnat1-mediated protective effect in RGC function. MAPK signaling activation has been reported to contribute to neuroprotection, and be involved in the development of including proliferation, differentiation, survival, and death. These biological processes may co-regulate to cope with diverse extracellular and intracellular stimuli [31] . In this study, we show novel evidence that MAPK signaling is involved in neuroprotection.
In conclusion, we show that Nmnat1 knockdown could aggravate RGC injury, and accelerate the development of RGC apoptosis in response to high glucose stress. Nmnat1 protects RGC against high glucose-induced injury via p38-MAPK signaling pathway. Nmnat1 may serve as a neuroprotective target for diabetes mellitus-related retinal neuropathy. 
